single exposure to 5-MeO-DMT can cause rapid and sustained reductions in symptoms of depression, anxiety and stress.

MDMA-AT for severe PTSD may also lead to subclinical improvements in alcohol use.

Current research doesn’t know much about the special risks and rewards for your generation, according to several scientific experts.

Psilocybin, MDMA, and ketamine can lead to a new sense of self and a release from rigid rules for people with anorexia, bulimia, and binge-eating disorder.

This is an excellent overview of what happened in the field of psychedelics in 2021 with an additional look ahead to what is likely to emerge in 2022.

Low doses of LSD are safe, but produce negligible changes in mood or cognition in healthy volunteers.

LSD changed creativity across modalities and measurement approaches.

Consuming small doses of psilocybin at regular intervals — a process known as microdosing — does not appear to improve symptoms of depression or anxiety

Our review shows that medical risks are often minimal, and that many – albeit not all – of the persistent negative perceptions of psychological risks are unsupported.

Researchers in the field of psychedelics hit the ground running at the turn of the new year.

2022 looks set to be another busy year for the psychedelics space, with a number of late-stage clinical trials commencing or wrapping

What credentials will likely be necessary to legally provide psychedelic therapy?

The purpose of this Primer is to provide those interested in the field of psychedelics with a concise and accessible overview of the scientific data.

Symptom reduction following ketamine infusions in severely ill patients suggest that ketamine, despite being inferior to ECT, can be a safe and valuable tool .

The Innovative Licensing and Access Pathway (ILAP) Innovation Passport has ben granted to MDMA as an adjunct to therapy for posttraumatic stress disorder (PTSD) in the United Kingdom (UK).

This review examines the positive and negative aspects of different formulations and routes of administration of DMT

Development of meaning-creating psychotherapies and further research findings in psychedelic therapies may contribute to more compassionate and mindful care.

Suicide is a global health concern, and innovative interventions that target suicidality are needed.

The present research aimed to uncover an emerging model of MDMA use grounded in the experiences of adult couples using MDMA privately and in the context of their committed relationships.

This study compared five psychedelic substance report groups and a non-psychedelic report group on quantitative linguistic markers.